Advertisement
Singapore markets open in 23 minutes

  • Straits Times Index

    3,332.80
    -10.55 (-0.32%)
     

  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     

  • Dow

    39,118.86
    -45.24 (-0.12%)
     

  • Nasdaq

    17,732.60
    -126.10 (-0.71%)
     

  • Bitcoin USD

    62,643.38
    +1,705.98 (+2.80%)
     

  • CMC Crypto 200

    1,297.80
    +13.97 (+1.09%)
     

  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     

  • Gold

    2,333.40
    -6.20 (-0.27%)
     

  • Crude Oil

    81.72
    +0.18 (+0.22%)
     

  • 10-Yr Bond

    4.3430
    +0.0550 (+1.28%)
     

  • Nikkei

    39,916.00
    +332.92 (+0.84%)
     

  • Hang Seng

    17,718.61
    +2.11 (+0.01%)
     

  • FTSE Bursa Malaysia

    1,590.09
    +5.15 (+0.32%)
     

  • Jakarta Composite Index

    7,063.58
    -6,967.95 (-49.66%)
     

  • PSE Index

    6,411.91
    +21.33 (+0.33%)
     

Glaukos: Q1 Earnings Snapshot

Associated Press Finance
·1-min read

ALISO VIEJO, Calif. (AP) — ALISO VIEJO, Calif. (AP) — Glaukos Corp. (GKOS) on Wednesday reported a loss of $40.8 million in its first quarter.

The Aliso Viejo, California-based company said it had a loss of 82 cents per share. Losses, adjusted for non-recurring costs, came to 70 cents per share.

The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 58 cents per share.

The glaucoma treatments developer posted revenue of $85.6 million in the period, topping Street forecasts. Nine analysts surveyed by Zacks expected $78.7 million.

ADVERTISEMENT

Glaukos expects full-year revenue in the range of $357 million to $365 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GKOS at https://www.zacks.com/ap/GKOS